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Cutaneous pigmentation is a major determinant of 
the cutaneous response to ultraviolet radiation, and 
consequently of the risk of developing skin cancer. 
Over the past 10 years, several genes involved in 
melanogenesis have been identified, including the 
melanocortin 1 receptor gene. Recent work on the 
melanocortin 1 receptor suggests that it is a key 
player in determining whether eumelanin or 
pheomelanin is predominantly produced both in vitro 
and in vivo. In the mouse, variants of this receptor, 
which dift"er in their ability to activate adenylyl cy-
, , O n account of the bequest of the late Ezekiah Hopkins, of Lebanon, Penn., U.S.A., there is now another vacancy open which entides a member of the League to a salary of four pounds a 
week for purely nominal services. All red-headed men who are 
sound in body and mind, and above the age of twenty-one years, 
are eligible." (from 'The Red-headed League,' in 'The Adventures 
of Sherlock Holmes' by Arthur Conan Doyle.) 
Although it makes for good rhetoric, dissociating genetic from 
environmental causes of disease, such that one forgets that genes 
only exert an effect in a defined environment and vice versa, makes 
for bad science. Understanding the causes of skin cancer provides a 
pertinent example. One can view the causes of melanoma or 
non-melanoma skin cancer as being predominandy environmental, 
or alternatively as being predominandy genetic. From an environ­
mental perspective, the major determinant world wide of skin 
cancer appears to be ultraviolet radiation: skin cancers arise more 
frequendy on sun-exposed areas; rates vary with latitude; and 
migrants from Anglo-Saxon communities to AustraIia show an 
elevated risk of both melanoma and non-melanoma skin cancer 
(Armstrong and Kricker, 1996). On the other hand, given that 
these large-scale population migrations, and increased leisure and 
travel, are recent phenomena, the major determinant world wide of 
skin cancer has been genetic, namely the pigmentary status of the 
individual. Rates of both melanoma and non-melanoma skin cancer 
are up to 50 times lower in Negroes, and 4 to 12 times lower in 
Japanese, than in Caucasians (Chuang et ai, 1995; Halder and 
Bridgeman-Shah, 1995). Even within Caucasian populations, how­
ever, possession of a collection of phenotypic features including red 
hair, tendency to freckle, and the usually associated inability to tan 
is associated with an up to 5-fold risk in melanoma and non­
melanoma skin cancer (Bliss et ai, 1995; Armstrong and Kricker, 
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clase, are associated with dift"erent coat colors. In 
humans, melanocortin 1 receptor variants are associ­
ated with red hair and fair skin, and work in progress 
from our laboratory suggests that certain melanocor­
tin 1 receptor variants may preferentially be associ­
ated with hair color rather than skin type. In addi­
tion, melanocortin 1 receptor variants are a risk 
factor, possibly independent of skin type, for mela­
noma susceptibility. Key worth: G-protein-coupled reap­
torlpigmentationlmelanomalgenetiu. joumal of Investigative 
Dermatology Symposium Proceedings 2:94-98. 1997 
1996). This actual relative risk is likely to be a considerable 
underestimate for two reasons. First, accurate skin typing is prob­
lematic (Rampen et ai, 1988), and second, individuals who are 
sensitive to the sun will tend to spend less time in the sun, resulting 
in an underestimation of the risks for those with sun sensitivity. 
Genetic approaches to the understanding of skin type, i.e., the 
degree to which individuals are liable to tan or burn in response to 
ultraviolet radiation, may seem hopeless. Whereas differences 
between the majority of Northern Europeans and Southern Euro­
peans are easily detected, skin typing as used clinically is at best a 
crude instrument, although up to the present there has been litde 
choice. Notwithstanding these difficulties, understanding the ge­
netics of pigmentation and the response to ultraviolet radiation are 
of major importance, not only because of their immediate relevance 
to melanoma and non-melanoma skin cancer but also because 
pigmentary differences between individuals are perhaps the most 
striking traits that distinguish individuals of our species. That 
changes in human pigmentation have occurred independendy in 
populations widely dispersed suggests that there is strong evolu­
tionary pressure to fit particular populations to a particular envi­
ronmental niche (Bodmer and Cavalli-Sforza, 1976; Kingdon, 
1993). In evolutionary terms it appears likely that, with the loss of 
body hair, the importance of interfollicular pigmentation as a 
method to protect the individual from the harmful effects of 
ultraviolet radiation assumed importance. Although, as observed in 
African albinos, the hazards of ultraviolet radiation are amply 
demonstrated by the development of skin tumors at an early age 
(and at an age that would influence biologic reproductive fitness), 
it seems likely that the major evolutionary drive toward the 
development of pigment relied more on the adverse biologic effects 
of sunburn with the consequent increased propensity to infection 
and acute illness (Luande et ai, 1985; Kingdon, 1993). Nevertheless 
the subsequent reduction or change of pigment in populations such 
as those currendy inhabiting Northern Europe needs to be ac­
counted for by more than the aforementioned gifts of Mrs Ezekiah 
Hopkins. Current evolutionary theory suggests that the possession 
of dark skin in populations where ambient ultraviolet radiation is 
low leads to a propensity to rickets due to impaired vitamin D 
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metabolism with the resulting biologic consequences (Kingdon, 
1993). As one moves progressively further north through Europe, 
skin color lightens in populations whose diets are cereal based. By 
contrast, in the Eskimos skin pigmentation is darker, an exception 
that some argue may be accounted for by their reliance not on a 
cereal-based diet but by a diet dependent on meat with a greater 
supply of fat-soluble vitamins (including vitamin D) (Bodmer and 
Cavalli-Sforza, 1976; Kingdon, 1993). 
Over the last 10 y, genetic approaches to disease and human 
physiology have proved extraordinarily powerful. The major intel­
lectual difficulty remains the framing of clinically relevant questions 
in such a way that genetic approaches can be undertaken: for 
pigmentation, as for so many other areas of research, murine 
genetics has been especially informative Oackson 1994). The 
identification of the murine extension locus as being the gene for 
the melanocortin 1 receptor (Mc1r) (Robbins et ai, 1993) has 
opened up opportunities to obtain a genetic handle on the study of 
the cutaneous response to ultraviolet radiation within human 
populations. In the present article we will review briefly the 
background to the cloning of the human melanocortin receptors, 
describe recent data on cellular expression of these receptors, and 
then present work from our own laboratory studying the associa­
tion between variants of the human melanocortin 1 receptor 
(MC1R) and cutaneous phenotype and associations between par­
ticular variants of the MC1R and melanoma. 
CLONING OF A FAMILY OF MELANOCORTIN 
RECEPTORS 
The human MC1R gene, encoding for a seven-pass transmembrane 
G-protein-coupled receptor of 317 amino acids, was cloned in 
1992 by two separate groups (Mountjoy et ai, 1992; Chhajlani & 
Wikberg, 1992). Mountjoy et al (1992) used degenerate oligonu­
cleotide primers from transmembrane domains 3 and 6 of earlier 
cloned G-protein-coupled receptors to amplify by PCR cDNA 
from a human melanoma that had been previously shown to 
contain a large number of [125I]iodo-Nle4-,D-Phe7-a-melanocyte­
stimulating hormone (a-MSH)-binding sites. Chhajlani and Wik­
berg (1992) similarly employed degenerate primers from these 
transmembrane domains but amplified from genomic DNA (this 
being possible because many G-protein-coupled receptors were 
known to be intronless), and subsequendy used the amplified 
product as a probe to detect an RNA band (only) in a melanoma 
cell line during a Northern blot hybridization with RNA from 
several tissue types. At the same time Mountjoy et al (1992) cloned 
the murine Mc1r and human adrenocorticotrophic hormone 
(ACTH) receptor (MC2R) genes and, on the basis of Southern 
hybridization of human genomic DNA at low stringency to a 
human MC1R probe, suggested that as many as five or six members 
of the melanocortin receptor gene family existed. To date, another 
three human melanocortin receptor genes (designated MC3R, 
MC4R, MC5R) have been identified (Chhajlani et ai, 1993; Gantz 
et ai, 1993a, 1993b). The MC1R has been mapped to human 
chromosome 16q24.3 by fluorescent in situ hybridization (FISH) 
analysis; however, the other melanocortin receptor genes are 
located elsewhere; 18p11.2 (MC2R), 20q13.2-q13.3 (MC3R), 
18q21.3 (MC4R), and 18p11.2 (MC5R) (Gantz et ai, 1993b, 1993c, 
1994a; Chowdhary et ai, 1995). Investigations on MC1R mRNA 
expression by northern hybridization have shown it to be present at 
relatively low levels in cultured melanocytes, but expression in 
melanoma cells varies from undetectable to highly abundant 
(Mountjoy et ai, 1992; Chhajlani and Wikberg, 1992; Cone et aI, 
1993; Chakraborty et ai, 1995; Suzuki et ai, 1996). Immunohisto­
chemistry using a polyclonal antibody against the MC1R protein 
has enabled detection of the antigen in COS-7 cells transfected with 
the MC1R gene and in melanoma tissue, but melanocytes in normal 
skin are not visualized with this antibody (Xia et aI, 1995). 
MC1R IS A KEY DETERMINANT OF PIGMENTATION 
MC1R seems to be the only melanocortin receptor expressed in 
cultured melanocytes and melanoma cells, and conversely MC1R 
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mRNA has not been detected so far in any of the other organs or 
tissues investigated (Mountjoy et aI, 1992; Chhajlani and Wikberg, 
1992; De Luca et ai, 1993; Siegrist et ai, 1994; Suzuki et ai, 1996). 
Expression of the ACTH receptor occurs in the adrenal gland and 
adipose tissue; MC3R is expressed in brain, placenta, and gastro­
intestinal tissues; MC4R is present in brain; and MC5R appears in 
various tissues including brain, skin, adipose tissue, adrenal gland, 
skeletal muscle, bone marrow, spleen, thymus, gonads, and uterus; 
at present it is unclear whether the MC5R expression observed in 
murine skin is due to the presence of subcutaneous fat or to its 
transcription in other cell types (Mountjoy et ai, 1992; Chhajlani et 
aI, 1993; Gantz et ai, 1993a, 1993b; Labbe et ai, 1994; Boston and 
Cone, 1996). Interestingly, radioligand-binding assays on immor­
talized human epidermal keratinocytes have demonstrated that 
these cells show binding for J3-melanocyte-stimulating hormone, 
but Suzuki et al were unable to detect specific mRNA transcript for 
MC1R in human epidermal keratinocytes and therefore suggested 
that keratinocytes may express another melanocortin receptor 
rather than MC1R (Chakraborty and Pawelek, 1993; Suzuki et ai, 
1996). Immunostaining of normal skin by Xia et al (1995) has also 
failed to identify any MC1R protein in keratinocytes in vivo. 
The central importance of the human MC1R gene in melano­
genesis was emphasized by the recent work by Chluba-de Tapia et 
al (1996) who induced melanin production in amelanotic mouse 
melanoma cells (which do not express their own mouse Mc1r) by 
stable transfection of the human MC1R gene. In spite of melano­
cytes having only one receptor, however, information from trans­
fection experiments and from ligand assays on cultured melano­
cytes/melanoma cells suggests that other ligands, in addition to 
a-melanocyte-stimulating hormone (a-MSH), including ACTH, 
J3-MSH, 'Y-MSH (and the synthetic analog Nle4-,D-Phe7-alpha 
MSH) can bind to the MC1R (Chhajlani and Wikberg, 1992; 
Mountjoy et aI, 1992; Suzuki et ai, 1996). Results from competitive 
binding assays and measurement of adenylyl cyclase activity I cAMP 
production in cells transfected with human MC1R, and in cultured 
human melanocytes, are generally consistent, with a-MSH = 
ACTH > {3-MSH > -y-MSH in the order of potency (Chhajlani and 
Wikberg, 1992; Mountjoy et ai, 1992; Suzuki et aI, 1996). The 
physiologic relevance of these in vitro binding studies, however, is 
at present unclear; although the proopiomelanocortin precursor 
peptide is present in human skin (and is upregulated by ultraviolet 
radiation), the relative contribution of the proopiomelanocortin 
breakdown products such as a-MSH and ACTH (which have also 
been detected in mammalian skin) to melanogenesis in vivo is 
unknown (Thody et ai, 1983; Farooqui et aI, 1993; Wintzen et ai, 
1996). The recent detection in human skin of the two prohormone 
convertases PCl and PC2, which are involved in the formation of 
ACTH and its cleavage to a-MSH, respectively, with higher 
immunoreactivity for pe2 in melanocytes suggests that the pattern 
of processing of proopiomelanocortin breakdown products in me­
lanocytes may diJfer from that in keratinocytes (A.J. Thody, 
personal communication). 
MICE AND HUMANS WITH MCIR VARIANTS HAVE 
ALTERED PIGMENTARY PHENOTYPES 
Mammalian coloring, including murine coat color, is in large part 
dependent on the relative amounts of eumelanin and pheomelanin 
that are produced (Burchill et aI, 1993; Jackson, 1994; Ozeki et ai, 
1995; Prota et aI, 1995). Similar diJferences are also seen in human 
hair, and both eumelanin and pheomelanin are found in interfol­
licular human epidermis (Thody et aI, 1991). Murine genetics has 
shown that various alleles of the extension locus are important in 
determining murine coat color (Robbins et ai, 1993). For instance, 
loss of function mutations of this locus result in recessive yellow mice. 
Conversely, dominant mutations increase the amount of black 
pigment (or eumelanin) and diminish the amount of yellow pig­
ment Oackson, 1994). Although the phenotype of yellow mice is 
different from that in red hair and may be thought to resemble the 
light colored hair found in Northern Europe, analysis of eumelanin 
and pheomelanin show that yellow mouse hair is rich in pheomela-
96 REES AND HEALY JID SYMPOSIUM PROCEEDINGS 
Table I. The Spectrwn of MC1R Variants Identmed in 222 Individualsd According to Skin Type 
Skin Type Ala64Ser Phe76Tyr Asp84Glu Asn91Asp Val92Met Thr95Met Va197ne AlalO3Val Leu106Gln Asp294His 
I-II 
II 
II-III 
III 
III-IV 
IV 
1 1 4 
4 
1 
1 
16 2 1 13 
5 
8 18 
1 
4 1 
1 
2 
• Integen in table refer to numbers of individuals with the MC1R variant. Infurmation on skin type not available for two cases with Alp84Glu variant. and for one case with 
Val92Met variant. Some individuals contained more than one MC1R variant; please refer to Valverde et at (1995) and Valverde et al (1996) for further details on homozygous. 
heterozygous. and compound heterozygous variants. 
nin and appears to be the murine counterpart of the red hair found 
in humans (prota, 1992; Prota et ai, 1995). Because of this and 
because of the known effects of MSH and ACTH on both murine 
and human pigmentation, we examined the MC1R as a candidate 
gene for red hair andlor skin type 1 in humans (Valverde et ai, 
1995). Because of the difficulties of skin typing we initially exam­
ined individuals showing the extremes of hair and skin pigmenta­
tion of phenotype. The MC1R gene from 30 unrelated individuals 
with different shades of red hair and a poor tanning response were 
sequenced. Controls with brown or black hair and a good tanning 
response were similarly investigated. Variants of the MC1R gene 
were found in 21 of the 30 red-headed fair-skinned individuals 
examined, but none were found in the 30 controls. A large number 
of variants were identified (see Table I). 
The majority of variants clustered in a region between the first 
cytoplasmic loop and the first extracelluar loop spanning the second 
transmembrane domain. The most common change, however, was 
an aspartate to histidine at codon 294 in the seventh transmembrane 
domain. Interestingly, whereas 13 individuals had only one change 
in the coding region, eight had two or more changes. PCR cloning 
of these established that seven of these eight individuals were 
compound heterozygotes. In order to extend these results to a more 
representative population, we went on to examine a further 7 S 
individuals who were classified according to their natural hair color 
at the age of 20 y and their skin type using the Fitzpatrick (1988) 
clinical skin typing, examining only those regions of the MC1R that 
had harbored abnormalities in the earlier study. Eighty two percent 
of individuals with light redl deep red hair had changes in one or 
both alleles compared to fewer than a quarter of the auburns, one 
third of those who were fair or blonde, and fewer than 20% of the 
brown or blacks. Changes in both alleles (29% of the total) were 
only found in those individuals who had light or deep red hair. 
Interestingly, when the individuals were classified according to 
their skin type, the association was even more striking: all the 
black- or brown-haired individuals who had changes in the MC1R 
were classified as skin types I or ll. We didn't detect any alterations 
in individuals with skin type IV, and only two of the skin type III 
subjects in this study contained MC1R variants. 
These data have several enigmatic and puzzling features and 
suggest important differences from that seen in the mouse. First, a 
large number of variants have been detected. Whereas some of 
these changes might be expected to be functionally significant, e.g., 
the replacement of an acidic residue with the basic one at codon 294 
and others in the second transmembrane region that might be 
expected to alter the a-helical structure, some of the variants may 
prove to be simple polymorphisms in linkage with other changes 
(perhaps in the promoter region), which alter the expression of the 
gene. Second, abnormalities were not found in all individuals with 
red hair. This is perhaps not surprising given the complex nature of 
human pigmentation and, as discussed below, given the possibility 
that the physiologic antagonist of the MC1R receptor, agouti, may 
also be important in determining human hair color. These results, 
however, do show that, unlike inbred mouse strains in which loss 
of function mutations are recessive (Robbins et ai, 1993), in humans 
the situation appears more complex: many individuals have been 
identified with a similar phenotype some of whom are compound 
heterozygotes and others are simple heterozygotes. It remains 
possible that some of the heterozygotes may have abnormalities 
outside the coding region, perhaps affecting gene expression, or, 
alternatively, that the results are in keeping with what we already 
know about red hair, i.e., that it does not appear to segregate as a 
simple Mendelian recessive trait. Interestingly, Barsh (1996) has 
reviewed the results in terms of relative risks rather than in classical 
Mendelian terms and points out that individuals who harbor a 
variant receptor have a relative risk for red hair of 1S-fold, but this 
risk rises to 170-fold among those individuals carrying two variant 
allele. Because the population studied was not a random one, 
however, this method of analysis may tend to overemphasize the 
importance of the putative red hair alleles. 
MC1R VARIANTS ARE A RISK FACTOR FOR 
CUTANEOUS MELANOMA 
As well as being important in understanding the biology of 
cutaneous pigmentation, the identification of variants of the MC1R 
gene in humans, although not entirely analogous to the situation in 
mice, may have more immediate medical consequences. Melanoma 
incidence is apparendy increasing rapidly in many Caucasian pop­
ulations (MacLennan et ai, 1992; Elder, 1995; Rees, 1996). Whereas 
several genetic events that are important in the development and 
progression of sporadic melanoma have been identified, little is 
known about the genetics of susceptibility to this neoplasm (Rees 
and Healy, 1996). Red hair and the inability to tan in response to 
ultraviolet radiation are known risk factors for the development of 
melanoma (Bliss et ai, 1995). It is to be expected, therefore, that 
there may be a preponderance of individuals with variant alleles 
among individuals who develop melanoma. If this were just the 
case, then genotypic examination may be a useful predictor of 
melanoma but one would question whether it would impart 
information not obtainable from the phenotype. On the other hand, 
the situation may be more complex than this initial interpretation. 
First, although associations between variant alleles and melanoma 
might be expected because of the association between variant 
alleles and skin type, the majority of individuals with red hair or 
skin type I do not develop melanoma. It seems possible that the 
possession of particular variants may not be equal in their biologic 
effect, raising the possibility that the presence of particular alleles 
may render certain individuals particularly at risk. Second, the 
majority of patients with melanoma do not have skin type I. Based 
on present evidence, the genetics of the MC1R in humans are 
complex, and it is possible that even in the absence of the features 
that render a person at increased risk, such as red hair or freckling, 
some individuals with dark hair who tan intermediately or well may 
also harbor variant alleles; there may be differences, therefore, 
between genotypic examination and phenotypic examination. Fi­
nally, there is some evidence that MSH may be important in 
controlling melanocyte growth in the context of melanoma pro­
gression (Lunec et ai, 1990; Lunec et ai, 1992; De Luca et ai, 1993; 
Suzuki et ai, 1996). If this is indeed the case, then variant receptor 
alleles could be associated with melanoma independent of the 
effects on cutaneous pigmentation. 
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In order to examine further these possibilities, we screened 43 
unrelated patients with sporadic cutaneous melanoma and 44 
unrelated control patients (Valverde et ai, 1996). The patient's skin 
type was assessed according to the Fitzpatrick scale and the history 
of freckling and hair color was taken. As expected, a weak 
association between melanoma and skin type was observed if skin 
type was treated as a quantitative variable (p = 0.046). In keeping 
with the previous work 20 of 43 melanoma patients harbored 
variant alleles compared with only eight of the 44 controls. The 
association between variant alleles and melanoma was significant 
with the relative risk of 3.91 (95% confidence intervals, 1.48 -
10.35). The population risk attributable to carriers, which provides 
a measure of what the disease incidence would be reduced by if the 
risk in carriers was reduced to the same level as the non-carriers, 
was 35%: more than one third of melanomas could be attributed to 
the presence of variant alleles in the population; for comparison, the 
relevant figure for melanoma cases due to germline p16INK4 
mutation is 3 to 5%. What was perhaps unexpected, at least in 
degree, however, was that the majority of variant alleles among 
individuals with melanoma comprised one particular variant, the 
Asp84Glu variant. Two individuals were homozygous for this 
variant and eight were heterozygous. Although at the biochemical 
level the functional significance of this change is as yet unknown, 
the importance of these results is highlighted by the finding that this 
variant was found in none of the control subjects studied as part of 
the melanoma study and was only found in two of 135 subjects in 
a previous study that included 47 subjects with red or auburn hair 
and 77 individuals who were skin type I or II (Valverde et ai, 1995). 
Thus, the Asp84Glu is rare even in a population enriched for those 
with marked sun sensitivity and red hair who are potentially at risk 
of melanoma development. Although the change from aspartate to 
glutamate appears minor, an aspartate at codon 84 is highly 
conserved throughout not only the melanocortin receptor family 
but also other G-protein-coupled receptors (Chhajlani and Wik­
berg, 1992; Mountjoy et ai, 1992; Chhajlani et ai, 1993; Gantz et ai, 
1993a, 1993b). As with previous studies of the variant alleles, it 
remains formally possible that this change may be in linkage 
dis-equilibrium with other changes outside the coding region of the 
MC1R; however, the degree of conservation throughout this family 
of receptors makes a direct causal role for this range at least 
plausible. 
FUTURE WORK 
The magnitude of the association between melanocortin 1 receptor 
variants and skin pigmentation and melanoma is perhaps surprising. 
Nevertheless, the work to date demonstrates the power of associ­
ation studies using candidate genes identified in the murine system 
to study human pigmentation. Association studies, however, need 
to be interpreted cautiously, and it will be important in the near 
future not only to carry out detailed family studies matching 
genotype to phenotype to define the mode of inheritance of the 
putative loss of function mutations, but also to examine allelic 
frequencies in different populations with different phenotypic char­
acteristics. The evidence implicating the MC1R in pigmentation 
comes from a variety of animals in addition to the mouse, including 
the horse, cow, and chicken (Robbins et ai, 1993; Johansson et ai, 
1994; Klungland et ai, 1995; Joerg et ai, 1996; Takeuchi et ai, 1996). 
Nevertheless, there are still major deficiencies in our mechanistic 
understanding of how the ligand(s) in binding to wild-type or 
variant receptor alters the ratio and amount of eumelanin and 
pheomelanin produced. An additional level of complexity may arise 
because, at least in the murine system, physiologic antagonists of 
G-protein-coupled receptors are also present. Agouti, which is 
produced in the follicular environment by keratinocytes, acts in a 
paracrine way as a competitive antagonist of MSH (Bultman et ai, 
1992; Miller et ai, 1993; Lu et ai, 1994; Millar et ai, 1995). For 
instance, in agouti mice the switch from eumelanin to pheomelanin 
and back to eumelanin is caused by alteration in agouti expression, 
inhibiting in a hair cycle-dependent way the reduction of eu- and 
pheomelanin (Miller et ai, 1995). It is possible, therefore, that not 
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only changes in MC1R, but also differences in expression or, 
conceivably, mutations [although as Barsh (1996) has argued this 
would be unusual in a ligand] might also account for the red­
headed and skin type 1 phenotype. 
It is not clear at present whether the reported variations in the 
MC1R gene are associated with red hair per se or with pale skin 
(Valverde et ai, 1995). The two characteristics do not always go 
hand in hand. For instance, in Irish populations there are many 
individuals with dark hair who are skin type I. Results on these are 
incomplete but preliminary observations from our laboratory sug­
gest that certain MC1R variants may preferentially be associated 
with hair color rather than skin type, and that these variants are 
found at different frequencies in groups of individuals with similar 
phenotypes from different European populations. 
Finally, the association of a particular alteration at codon 84 in 
melanomas in the UK population needs to be confirmed or refuted 
in other populations. The current data suggest that genotype may 
predict tumor risk better than phenotype. This may relate to the 
difficulties of skin typing using the Fitzpatrick classification 
(Rampen et aI, 1988), but at least raises the possibility that in 
melanoma the influence of the MC1R signaling pathway may be 
additional to any effects on the pigmentary phenotype. It would be 
of interest to see whether similar MC1R variants are present in 
non-melanoma skin cancer; if no association exists it may be that 
the effect of MC1R variants in melanoma are independent of the 
skin type phenotype and that their influence on the growth and 
development of melanocytes and melanoma cells is via the MSH­
signaling pathway. 
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